Abstract
Brain and all other neural tissue consume glucose without assistance from insulin. Till about 2 decades ago, it was therefore assumed that insulin has little to do with cerebral/neural pathologies. However, there is a large body of highly beneficial evidence both in animal and human experiments of intricate nature and evidence from large trials. It is certain that for the preservation of the structure and for the preservation of its functions in an uninterrupted optimal manner of all neural tissues adequacy of insulin is an extremely important factor. This chapter highlights this importance in considerable detail, with reference to diabetic neuropathic afflictions in particular. This will or should increase the use of insulin as early, adequately and with understanding of the doctor and for the patients about the valuable positive impact of this wonderful drug on their neuropathic and overall well-being.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grote CW, Wright DE. A role for insulin in diabetic neuropathy. Front Neurosci. 2016; https://doi.org/10.3389/fnins.2016.00581.
Grillo CA, Piroli GG, Lawrence RC, Wrighten SA, Green AJ, Wilson SP, et al. Hippocampal insulin resistance impairs spatial learning and synaptic plasticity. Diabetes. 2015;64:3927–36. https://doi.org/10.2337/db15-0596.
Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci. 2002a;5:566–72. https://doi.org/10.1038/nn0602-861.
Sugimoto K, Murakawa Y, Sima AA. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J Peripher Nerv Syst. 2002;7:44–53. https://doi.org/10.1046/j.1529-8027.2002.02005.x.
Chiu SL, Cline HT. Insulin receptor signaling in the development of neuronal structure and function. Neural Dev. 2010;5:7. https://doi.org/10.1186/1749-8104-5-7.
Murakawa Y, Zhang W, Pierson CR, Brismar T, Ostenson CG, Efendic S, et al. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabetes Metab Res Rev. 2002;18:473–83. https://doi.org/10.1002/dmrr.326.
Brussee V, Cunningham FA, Zochodne DW. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes. 2004;53:1824–30. https://doi.org/10.2337/diabetes.53.7.1824.
Toth C, Brussee V, Zochodne DW. Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia. 2006b;49:1081–8. https://doi.org/10.1007/s00125-006-0169-8.
Guo G, Kan M, Martinez JA, Zochodne DW. Local insulin and the rapid regrowth of diabetic epidermal axons. Neurobiol Dis. 2011;43:414–21. https://doi.org/10.1016/j.nbd.2011.04.012.
Francis GJ, Martinez JA, Liu WQ, Zochodne DW, Hanson LR, Frey WH II, et al. Motor end plate innervation loss in diabetes and the role of insulin. J Neuropathol Exp Neurol. 2011;70:323–39. https://doi.org/10.1097/NEN.0b013e318215669a.
Sugimoto K, Murakawa Y, Zhang W, Xu G, Sima AA. Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms. Diabetes Metab Res Rev. 2000;16:354–63. https://doi.org/10.1002/1520-7560(200009/10)16:5<354::AID-DMRR149>3.0.CO;2-H.
Sugimoto K, Murakawa Y, Sima AA. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J Peripher Nerv Syst. 2002;7:44–53. https://doi.org/10.1046/j.1529-8027.2002.02005.x.
Shettar A, Muttagi G. Developmental regulation of insulin receptor gene in sciatic nerves and role of insulin on glycoprotein P0 in the Schwann cells. Peptides. 2012;36:46–53. https://doi.org/10.1016/j.peptides.2012.04.012.
Baiou D, Santha P, Avelino A, Charrua A, Bacskai T, Matesz K, et al. Neurochemical characterization of insulin receptor-expressing primary sensory neurons in wild-type and vanilloid type 1 transient receptor potential receptor knockout mice. J Comp Neurol. 2007;503:334–47. https://doi.org/10.1002/cne.21389.
Sathianathan V, Avelino A, Charrua A, Santha P, Matesz K, Cruz F, et al. Insulin induces cobalt uptake in a subpopulation of rat cultured primary sensory neurons. Eur J Neurosci. 2003;18:2477–86. https://doi.org/10.1046/j.1460-9568.2003.03004.x.
Van Buren JJ, Bhat S, Rotello R, Pauza ME, Premkumar LS. Sensitization and translocation of TRPV1 by insulin and IGF-I. Mol Pain. 2005;1:17. https://doi.org/10.1186/1744-8069-1-17.
Lilja J, Laulund F, Forsby A. Insulin and insulin-like growth factor type-I up-regulate the vanilloid receptor-1 (TRPV1) in stably TRPV1-expressing SH-SY5Y neuroblastoma cells. J Neurosci Res. 2007;85:1413–9. https://doi.org/10.1002/jnr.21255.
Pabbidi RM, Yu SQ, Peng S, Khardori R, Pauza ME, Premkumar LS. Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity. Mol Pain. 2008;4:9. https://doi.org/10.1186/1744-8069-4-9.
Singh B, Xu Y, McLaughlin T, Singh V, Martinez JA, Krishnan A, et al. Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin. J Neurochem. 2012;121:263–76. https://doi.org/10.1111/j.1471-4159.2012.07681.x.
Snyder EY, Kim SU. Insulin: is it a nerve survival factor. Brain Res. 1980;196:565–71. https://doi.org/10.1016/0006-8993(80)90426-6.
Bothwell M. Insulin and somatomedin MSA promote nerve growth factor independent neurite formation by cultured chick dorsal root ganglionic sensory neurons. J Neurosci Res. 1982;8:225–31. https://doi.org/10.1002/jnr.490080212.
Recio-Pinto E, Lang FF, Ishii DN. Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells. Proc Natl Acad Sci U S A. 1984;81:2562–6. https://doi.org/10.1073/pnas.81.8.2562.
Recio-Pinto E, Rechler MM, Ishii DN. Effects of insulin, insulin like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons. J Neurosci. 1986;6:1211–9.
Jones DM, Tucker BA, Rahimtula M, Mearow KM. The synergistic effects of NGF and IGF-1 on neurite growth in adult sensory neurons: convergence on the PI 3-kinase signaling pathway. J Neurochem. 2003;86:1116–28. https://doi.org/10.1046/j.1471-4159.2003.01925.x.
Fernyhough P, Mill JF, Roberts JL, Ishii DN. Stabilization of tubulin mRNAs by insulin and insulin-like growth factor I during neurite formation. Brain Res Mol Brain Res. 1989;6:109–20. https://doi.org/10.1016/0169-328X(89)90044-2.
Li ZG, Zhang W, Sima AA. C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells. Diabetes Metab Res Rev. 2003;19:375–85. https://doi.org/10.1002/dmrr.389.
Skaper SD, Selak I, Varon S. Molecular requirements for survival of cultured avian and rodent dorsal root ganglionic neurons responding to different trophic factors. J Neurosci Res. 1982;8:251–61. https://doi.org/10.1002/jnr.490080215.
Huang TJ, Verkhratsky A, Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol Cell Neurosci. 2005;28:42–54. https://doi.org/10.1016/j.mcn.2004.08.009.
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231–41. https://doi.org/10.1016/s0092-8674(00)80405-5.
Eckersley L. Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol. 2002;50:293–321. https://doi.org/10.1016/S0074-7742(02)50081-7.
Shetter AR, Muttagi G, Sagar CB. Expression and localization of insulin receptors in dissociated primary cultures of rat Schwann cells. Cell Biol Int. 2011;35:299–304. https://doi.org/10.1042/CBI20100523.
Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, Oda H, et al. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J Neurosci. 2004;24:6724–32. https://doi.org/10.1523/jneurosci.5520-03.2004.
Liang G, Cline GW, Macica CM. IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination. Glia. 2007;55:632–41. https://doi.org/10.1002/glia.20496.
Rachana KS, Manu MS, Advirao GM. Insulin influenced expression of myelin proteins in diabetic peripheral neuropathy. Neurosci Lett. 2016;629:110–5. https://doi.org/10.1016/j.neulet.2016.06.067.
Xu QG, Li XQ, Kotecha SA, Cheng C, Sun HS, Zochodne DW. Insulin as an in vivo growth factor. Exp Neurol. 2004;188:43–51. https://doi.org/10.1016/j.expneurol.2004.03.008.
Toth C, Brussee V, Martinez JA, McDonald D, Cunningham FA, Zochodne DW. Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience. 2006a;139:429–49. https://doi.org/10.1016/j.neuroscience.2005.11.065.
White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab. 2002;283:E413–22. https://doi.org/10.1152/ajpendo.00514.2001.
Plum L, Schubert M, Brüning JC. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab. 2005;16:59–65. https://doi.org/10.1016/j.tem.2005.01.008.
Choeiri C, Staines W, Messier C. Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience. 2002;111:19–34. https://doi.org/10.1016/S0306-4522(01)00619-4.
Leloup C, Arluison M, Kassis N, Lepetit N, Cartier N, Ferré P, et al. Discrete brain areas express the insulin-responsive glucose transporter GLUT4. Brain Res Mol Brain Res. 1996;38:45–53. https://doi.org/10.1016/0169-328X(95)00306-D.
Baura GD, Foster DM, Porte D Jr, Kahn SE, Bergman RN, Cobelli C, et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest. 1993;92:1824–30. https://doi.org/10.1172/JCI116773.
Wang YY, Lui PC, Li JY. Receptor-mediated therapeutic transport across the blood-brain barrier. Immunotherapy. 2009;1:983–93. https://doi.org/10.2217/imt.09.75.
Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154:635–41. https://doi.org/10.1093/aje/154.7.635.
Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care. 2007;30:842–7. https://doi.org/10.2337/dc06-2011.
Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA, et al. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer’s disease and correction by insulin. J Neurosci Res. 2008;86:3265–74. https://doi.org/10.1002/jnr.21787.
Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E. Type 1 diabetes exaggerates features of Alzheimer’s disease in APP transgenic mice. Exp Neurol. 2010;223:422–31. https://doi.org/10.1016/j.expneurol.2009.11.005.
Jolivalt CG, Calcutt NA, Masliah E. Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer’s disease. Neuroscience. 2012;202:405–12. https://doi.org/10.1016/j.neuroscience.2011.11.032.
Fadel JR, Jolivalt CG, Reagan LP. Food for thought: the role of appetitive peptides in age-related cognitive decline. Ageing Res Rev. 2013;12:764–76. https://doi.org/10.1016/j.arr.2013.01.009.
Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol. 2011;71:365–76. https://doi.org/10.1111/j.1365-2125.2010.03830.x.
Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122:1316–38. https://doi.org/10.1172/JCI59903.
Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T. Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging. 2011;32:1626–33. https://doi.org/10.1016/j.neurobiolaging.2009.10.009.
Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69:29–38. https://doi.org/10.1001/archneurol.2011.233.
Zochodne DW. Mechanisms of diabetic neuron damage: molecular pathways. Handb Clin Neurol. 2014;126:379–99. https://doi.org/10.1016/B978-0-444-53480-4.00028-X.
Zochodne DW. Diabetes and the plasticity of sensory neurons. Neurosci Lett. 2015;596:60–5. https://doi.org/10.1016/j.neulet.2014.11.017.
Diabetes Control Complications Trial Research Group. The effect of intensive diabetes therapy on the development, and progression of neuropathy. Ann Intern Med. 1995a;122:561–8. https://doi.org/10.7326/0003-4819-122-8-199504150-00001.
Diabetes Control Complications Trial Research Group. Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial. Ann Neurol. 1995b;38:869–80. https://doi.org/10.1002/ana.410380607.
Romanovsky D, Wang J, Al-Chaer ED, Stimers JR, Dobretsov M. Comparison of metabolic and neuropathy profiles of rats with streptozotocin-induced overt and moderate insulinopenia. Neuroscience. 2010;170:337–47. https://doi.org/10.1016/j.neuroscience.2010.06.059.
Romanovsky D, Cruz NF, Dienel GA, Dobretsov M. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats. Neurobiol Dis. 2006;24:384–94. https://doi.org/10.1016/j.nbd.2006.07.009.
Chen DK, Frizzi KE, Guernsey LS, Ladt K, Mizisin AP, Calcutt NA. Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst. 2013;18:306–15. https://doi.org/10.1111/jns5.12044.
Hoybergs YM, Meert TF. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy. Neurosci Lett. 2007;417:149–54. https://doi.org/10.1016/j.neulet.2007.02.087.
Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev. 2000;80:315–60.
Kalichman MW, Powell HC, Mizisin AP. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol. 1998;95:47–56.
Chowdhury SK, Zherebitskaya E, Smith DR, Akude E, Chattopadhyay S, Jolivalt CG, et al. Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment. Diabetes. 2010;59:1082–91. https://doi.org/10.2337/db09-1299.
Grote CW, Morris JK, Ryals JM, Geiger PC, Wright DE. Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathy. Exp Diabetes Res. 2011;2011:212571. https://doi.org/10.1155/2011/212571.
Kim B, McLean LL, Philip SS, Feldman EL. Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. Endocrinology. 2011;152:3638–47. https://doi.org/10.1210/en.2011-0029.
Aoki TT, Grecu EO, Arcangeli MA, Benbarka MM, Prescott P, Ahn JH. Chronic intermittent intravenous insulin therapy: a new frontier in diabetes therapy. Diabetes Technol Ther. 2001;3(1). Mary Ann Liebert, Inc.
Navarro X, DER S, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol. 1997;42(5):727.
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med. 2001;345:1359–67. https://doi.org/10.1056/NEJMoa011300.
Dabbya R, Sadeha M, Lampla Y, Gilad R, Watemberg N. Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetes patients. Biomed Pharmacother. 2009;63(10):707–9.
Archer A, Watkins PJ, Thomas PK. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatr. 1983;46(6):491–9.
Leow MKS, Wyckoff J. Under-recognised paradox of neuropathy from rapid glycemic control. Postgrad Med J. 2005;81(952):103–7.
Larsen PR, Kronenberg HM, et al. Williams Textbook of Endocrinology. 10th ed. Philadelphia; 2002.
Ibitoye R, Rajbhandari SM. Neuropathic truncal pain – a case series. Q J Med. 2012;105(10):1027–31.
Watkins. ABC of diabetes. 5th ed. London: BMJ Publishing Group; 2003. p. 32–7.
Further Reading
He is also referred to the chapter on Physiology of Insulin in the author’s volume on – ‘Towards Optimal Management of Diabetes in Surgery,’ also published by SpringerNature.
National Guidelines for Management of Diabetic Foot Diabetic Foot Society of India in November 2017.
The reader is referred to this paper [66.Oki Thomas et al., see ref. below for an excellent expose of the physiology of insulin in normal and its changes after the development of diabetes.
Towards ‘Optimal Management of Diabetes in Surgery’ published by Springer in August 2019.
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med. 2001;345:1359–67. https://doi.org/10.1056/NEJMoa011300.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kelkar, S. (2020). Insulin and Diabetic Peripheral Nerve Pathologies. In: Diabetic Neuropathy and Clinical Practice. Springer, Singapore. https://doi.org/10.1007/978-981-15-2417-2_13
Download citation
DOI: https://doi.org/10.1007/978-981-15-2417-2_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2416-5
Online ISBN: 978-981-15-2417-2
eBook Packages: MedicineMedicine (R0)